Market Overview:
The global injectable drug delivery system market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in injectable drug delivery systems. Based on type, the global injectable drug delivery system market is segmented into conventional devices, self-injecting devices, and others. The conventional devices segment is further sub-segmented into vials & syringes and cartridges & pens. The self-injecting devices segment is further sub-segmented into autoinjectors and pen injectors. Based on application, the global injectable drug delivery system market is divided into hospital use, clinic use, personal use (home care), and other applications (research institutes).
Product Definition:
Injectable drug delivery system is a technique of delivering the drugs directly into the bloodstream. It is used to deliver the large and bulky molecules which are not able to cross through the skin or mucous membranes. The importance of injectable drug delivery system is that it provides a rapid and reliable method of drug administration.
Conventional Devices:
Conventional devices are the most commonly used medical devices. They have been used for a long time and have proven to be effective in treating several diseases and disorders. However, as these are conventional, there are many alternatives available which can be used instead of these devices; some of them may even prove to be more effective than the conventional ones.
Self Injecting Devices:
Self-injecting devices are portable devices used to inject drugs. They comprise of needles, cartridges, and syringes that can be used by patients at home or in clinics without the help of a healthcare professional. Self-injecting drug delivery systems have been designed for people with reduced mobility who cannot use conventional injection equipment or those who do not have access to medical services.
Application Insights:
The hospital application segment held the largest share of 60.0% in 2017. The rising prevalence of chronic diseases, such as diabetes and cardiovascular diseases, is expected to drive the demand for GIDDS devices in hospitals over the forecast period. In addition, an increase in healthcare expenditure is anticipated to boost industry growth over the forecast period.
Clinic applications accounted for 39.1% share of global revenue in 2017 due to high adoption rates of these devices across clinics and personal care homes worldwide due to its ease of use.
Regional Analysis:
North America dominated the global market in 2017 owing to factors such as favorable reimbursement policies, rising incidence of chronic diseases, and increasing adoption of advanced technologies. Moreover, presence of major players in this region is also expected to drive the market over the forecast period. The Asia Pacific regional market for INJECT drug delivery systems is anticipated to witness lucrative growth during the forecast period due to factors such as improving healthcare infrastructure and growing target population base. In addition, economic development in countries like India and China are also contributing towards increased demand for these devices within APAC region.
The Latin American regional market held a considerable share within INJECT drug delivery system industry space in 2017 due to factors such as high prevalence of infectious diseases & increasing geriatric population prone toward various chronic conditions (CPC).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. Injectable drug delivery systems offer a more targeted and controlled way to administer drugs to patients suffering from chronic diseases, which helps improve their treatment outcomes.
- Technological advancements: The injectable drug delivery system market is witnessing rapid technological advancements, with new products being launched regularly. This has helped boost the adoption rates of these systems among healthcare professionals and patients alike.
- Rising demand for self-injection devices: There is a growing demand for self-injection devices, especially in developed countries where patients are increasingly becoming comfortable with using such devices for their own care needs. Injectable drug delivery systems that can be used by patients themselves are likely to witness strong growth in the coming years owing to this trend..
Scope Of The Report
Report Attributes
Report Details
Report Title
Injectable Drug Delivery System Market Research Report
By Type
Conventional Devices, Self Injecting Devices, Others
By Application
Hospital, Clinic, Personal, Other
By Companies
Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer AG, Schott AG, Eli Lilly and Company, Terumo Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Injectable Drug Delivery System Market Report Segments:
The global Injectable Drug Delivery System market is segmented on the basis of:
Types
Conventional Devices, Self Injecting Devices, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Personal, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton, Dickinson and Company
- Baxter International
- Pfizer
- Gerresheimer AG
- Schott AG
- Eli Lilly and Company
- Terumo Corporation
Highlights of The Injectable Drug Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Conventional Devices
- Self Injecting Devices
- Others
- By Application:
- Hospital
- Clinic
- Personal
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Injectable Drug Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An injectable drug delivery system is a medical device that helps administer medications by injecting them directly into the body.
Some of the major companies in the injectable drug delivery system market are Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer AG, Schott AG, Eli Lilly and Company, Terumo Corporation.
The injectable drug delivery system market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Injectable Drug Delivery System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Injectable Drug Delivery System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Injectable Drug Delivery System Market - Supply Chain
4.5. Global Injectable Drug Delivery System Market Forecast
4.5.1. Injectable Drug Delivery System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Injectable Drug Delivery System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Injectable Drug Delivery System Market Absolute $ Opportunity
5. Global Injectable Drug Delivery System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Injectable Drug Delivery System Market Size and Volume Forecast by Type
5.3.1. Conventional Devices
5.3.2. Self Injecting Devices
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Injectable Drug Delivery System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Injectable Drug Delivery System Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Personal
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Injectable Drug Delivery System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Injectable Drug Delivery System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Injectable Drug Delivery System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Injectable Drug Delivery System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Injectable Drug Delivery System Demand Share Forecast, 2019-2026
9. North America Injectable Drug Delivery System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Injectable Drug Delivery System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Injectable Drug Delivery System Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Personal
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Injectable Drug Delivery System Market Size and Volume Forecast by Type
9.7.1. Conventional Devices
9.7.2. Self Injecting Devices
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Injectable Drug Delivery System Demand Share Forecast, 2019-2026
10. Latin America Injectable Drug Delivery System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Injectable Drug Delivery System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Injectable Drug Delivery System Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Personal
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Injectable Drug Delivery System Market Size and Volume Forecast by Type
10.7.1. Conventional Devices
10.7.2. Self Injecting Devices
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Injectable Drug Delivery System Demand Share Forecast, 2019-2026
11. Europe Injectable Drug Delivery System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Injectable Drug Delivery System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Injectable Drug Delivery System Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Personal
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Injectable Drug Delivery System Market Size and Volume Forecast by Type
11.7.1. Conventional Devices
11.7.2. Self Injecting Devices
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Injectable Drug Delivery System Demand Share, 2019-2026
12. Asia Pacific Injectable Drug Delivery System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Injectable Drug Delivery System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Injectable Drug Delivery System Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Personal
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Injectable Drug Delivery System Market Size and Volume Forecast by Type
12.7.1. Conventional Devices
12.7.2. Self Injecting Devices
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Injectable Drug Delivery System Demand Share, 2019-2026
13. Middle East & Africa Injectable Drug Delivery System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Injectable Drug Delivery System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Injectable Drug Delivery System Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Personal
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Injectable Drug Delivery System Market Size and Volume Forecast by Type
13.7.1. Conventional Devices
13.7.2. Self Injecting Devices
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Injectable Drug Delivery System Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Injectable Drug Delivery System Market: Market Share Analysis
14.2. Injectable Drug Delivery System Distributors and Customers
14.3. Injectable Drug Delivery System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Becton, Dickinson and Company
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Gerresheimer AG
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Schott AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Eli Lilly and Company
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Terumo Corporation
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
